Corps Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Hold
1,968
0.4% 53
2026
Q1
$481K Sell
1,968
-15
-0.8% -$3.49K 0.42% 59
2025
Q4
$410K Buy
1,983
+684
+53% +$135K 0.42% 56
2025
Q3
$241K Buy
+1,299
New +$223K 0.36% 42
2025
Q2
Sell
-6,338
Closed -$1.05M 65
2025
Q1
$1.05M Sell
6,338
-99
-2% -$15.5K 1.11% 32
2024
Q4
$931K Buy
+6,437
New +$997K 0.94% 34

Other funds holding JNJ

Corps Capital Advisors's JNJ Position: Q2 2026 in Review

Corps Capital Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,968 shares worth $500K. The position accounts for 0.4% of the portfolio, ranked #53.

Corps Capital Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.05M in Q1 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Corps Capital Advisors held 1,968 shares of Johnson & Johnson worth $500K as of Q2 2026.
  • Corps Capital Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.4% of Corps Capital Advisors's portfolio in Q2 2026, its #53 holding.
  • Corps Capital Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Corps Capital Advisors's Johnson & Johnson position peaked at $1.05M in Q1 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Corps Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.